Physician

Gregory Lucien Fenton, M.D.

According to 2025 Medicare claims, Gregory Fenton, M.D. (NPI: 1114136959) practices ophthalmology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Du Page, IL. This provider's primary affiliated billing organization is WHEATON EYE CLINIC LTD (NPI: 1801883004; TIN: 362709692) and primary practice location at 60187-3152. Fenton is affiliated with the Northwestern Medicine Health Network ACO LLC (ACO ID: A5444), participating under the MSSP model.

Fenton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,477 traditional Medicare patients, billed 58,628 HCPCS/CPT codes, and received $2,999,807 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 954 prescription claims across 239 beneficiaries totaling $45,700 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $19,934 to $45,700. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$3.0M2015 Medicare payment: $2,100,786 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,574,408 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,598,074 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,755,593 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,696,446 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,748,111 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,871,490 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,604,235 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,834,661 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,999,807 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201583411,579$2,100,786
201685112,450$2,574,408
201779712,463$2,598,074
201875712,360$2,755,593
201989212,148$2,696,446
202088812,077$2,748,111
20211,15112,803$2,871,490
20221,31215,268$2,604,235
20231,39647,259$2,834,661
20241,47758,628$2,999,807

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$26K$53K2015 Drug cost: $19,934 (USD; Tot_Drug_Cst)2016 Drug cost: $22,943 (USD; Tot_Drug_Cst)2017 Drug cost: $23,218 (USD; Tot_Drug_Cst)2018 Drug cost: $22,629 (USD; Tot_Drug_Cst)2019 Drug cost: $26,238 (USD; Tot_Drug_Cst)2020 Drug cost: $33,592 (USD; Tot_Drug_Cst)2021 Drug cost: $29,625 (USD; Tot_Drug_Cst)2022 Drug cost: $50,723 (USD; Tot_Drug_Cst)2023 Drug cost: $52,527 (USD; Tot_Drug_Cst)2024 Drug cost: $45,700 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015104332$19,934
2016111372$22,943
2017109367$23,218
2018111400$22,629
2019130513$26,238
2020143557$33,592
2021200783$29,625
2022227997$50,723
20232501,013$52,527
2024239954$45,700

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1841,542$658
67028Injection of drug into eye3921,880$94
92014Established patient complete exam of visual system1,1451,486$91
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more389812$66
92134Imaging of retina1,3183,519$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate39411,694$10,771
ProlensaBromfenac Sodium211,286$9,235
Bromfenac SodiumBromfenac Sodium211,341$4,762
Ketorolac TromethamineKetorolac Tromethamine1806,026$2,557
DifluprednateDifluprednate17465$1,695

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Gregory Lucien Fenton, M.D.?

Tedicare shows public-source Medicare data for Gregory Lucien Fenton, M.D. (NPI 1114136959), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gregory Lucien Fenton, M.D. have ACO affiliation data?

Gregory Lucien Fenton, M.D. is shown with ACO affiliation data for Northwestern Medicine Health Network ACO LLC (MSSP, ACO ID A5444).

What billing organization is linked to Gregory Lucien Fenton, M.D.?

Gregory Lucien Fenton, M.D. is linked to WHEATON EYE CLINIC LTD (billing NPI 1801883004) in the available physician profile data.

Does Gregory Lucien Fenton, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.